Find an expert

I was awarded my PhD in Computational Biophysics from the University of Western Australia (2012) for my work on combining molecular modelling and simulation approaches with fluorescence spectroscopy experiments to study mechanosensitive ion channels.

Following this, I carried out Postdoctoral work at the University of Queensland and Curtin University, funded by Early Career Fellowships from the Swiss National Science Foundation and the Australian National Health and Research Council (NHMRC). In 2019, I joined UTS under a UTS Chancellor's Postdoctoral Research Fellowship and started my independent research group. In 2021, I returned to the University of Queensland as a Senior Lecturer.

Apart from my research, I am a passionate advocate for mental health in academia and

supporting PhD students. My teaching and supervision are guided by encouraging students to become 'critical thinkers'. I practice mindful leadership and aim to integrate kindness and gratitude into how I lead my research team.

Pratap is an IP Strategist and Patent researcher. He has expertise in dealing with Intellectual Property issues in relation to emerging technologies such as Artificial Intelligence (AI), 3D bioprinting and synthetic biology. He is currently a Postdoctoral fellow at TC Bernie School of Law, University of Queensland, Australia. Pratap pursued his PhD from the Centre for Law and Genetics, University of Tasmania, Australia where his research was focused on "Patenting issues related to Bioprinted tissues and Bioinks." In 2018, he was invited by Govt. of Japan to assist the Japanese Patent Office (JPO) in harmonizing Japanese Patent Law in relation to AI. In 2017, he completed his Master of Law (LLM) in Intellectual Property from the World Intellectual Property Organization (WIPO), Geneva and the Queensland University of Technology, Australia. He is the recipient of the prestigious International Fellowship offered by WIPO. He holds a Master's degree in Genomics from the Central University of Kerala, India and a Bachelor’s degree in Biotechnology, Microbiology, and Chemistry from Acharya Nagarjuna University, India. Pratap also holds a Postgraduate Diploma in Patent informatics from the Academy of Scientific and Innovative Research (AcSIR) at the CSIR Unit of Research and Development of Information Products (URDIP), India and worked as a Patent researcher in the same.

Taylor Dick is a Senior Lecturer in The School of Biomedical Sciences. She was awarded her PhD in 2016 from Simon Fraser University (Vancouver, Canada). Her PhD research, in partnership with the Concord Field Station at Harvard University, focused on developing an experimental and modelling framework to predict in vivo motor function using advanced image-driven musculoskeletal models. Following this, she conducted a Postdoctoral Fellowship in the Joint Department of Biomedical Engineering at North Carolina State University- The University of North Carolina (Chapel Hill) where her research focused on using wearable assistive devices (e.g., exoskeletons and prosthetics) to augment or restore movement-with a particular focus on how devices influence lower limb biomechanics and neuromuscular function. She has implemented innovative imaging approaches to discover how humans recover from unexpected perturbations during movement, which provided critical biological insight for the design of robotic devices capable of assisting movement in real-world environments.

Taylors research team have developed a uniquely integrative and highly translational approach to studying neuromuscular function that combines motion analysis, advanced tissue imaging, and muscuoloskeletal modelling to answer fundamental questions about how movement underpins evolution, health, and disease. Her current research is focused on.

• Exploring the mechanisms of neuromuscular function using both experimental and modelling approaches
• Understanding how the anatomy and biomechanics of the musculoskeletal system adapt to challenges such as size, age, and disease. To do this, her team has developed quantitative imaging technologies to visualize and interrogate the mechanisms that underpin motor function in humans and other animals
• Designing and applying wearable assistive technologies, such as exoskeletons and prosthetics, to enhance performance in healthy individuals or to restore mobility in those with deficits.

Taylor has established herself internationally as an emerging leader in biomechanics research. This reputation is supported by prestigious awards, invited talks and review papers, and media attention. Her research has been funded through competitive grant schemes and industry partnerships, with total research support exceeding $3.6 million. Her contributions to research and mentorship have been recognized with a 2024 Queensland Tall Poppy Award, 2024 International Union of Physiologists Junior Faculty Award; 2024 International Society of Electrophysiology and Kinesiology Kevin P. Granata Award, and the 2021 International Society of Biomechanics Jaquelin Perry Emerging Scientist Award. Taylor has been nominated (2020 and 2021) for the Faculty of Medicine Rising Star of the Year Award. Taylor is an elected Executive Council member of the International Society of Biomechanics (ISB) and the elected Chairperson of the Comparative Neuromuscular Biomechanics Technical group. She is a passionate promotor of STEM for young girls—having co-developed the led a government-funded nationwide program to boost girls’ engagement in STEM, BRInC https://www.canberra.edu.au/about-uc/faculties/health/brinc

She currently advises 12 PhD candidates, 1 Master’s student, and 5 Honours students. She has successfully advised 5 PhD, 2 Master’s and 9 Honours students to completion since commencing her faculty position at UQ in 2017.

For more information about her program of research, visit her lab website: https://biomedical-sciences.uq.edu.au/research/groups/neuromuscular-biomechanics

Plant viruses and horticultural crop improvement

Dr Dietzgen is internationally recognised for his work on plant virus characterisation, detection and engineered resistance. Before joining UQ, Dr Dietzgen was a Science Leader in Agri-Science in the Queensland Department of Employment, Economic Development and Innovation. He previously held research positions at the University of Adelaide, University of California, Cornell University and University of Kentucky. Dr Dietzgen’s research interests are in molecular virus-plant-insect interactions, virus biodiversity and evolution, and disease resistance mechanisms. His focus is on the biology of RNA viruses in the family Rhabdoviridae and the molecular protein interactions of plant-adapted rhabdoviruses and tospoviruses. He has published extensively on plant virus characterisation and genetic variability, RNAi- mediated virus resistance and diagnostic technologies with 20 review articles and book chapters and over 65 peer-reviewed publications.

Plants, unlike animals, are amazingly plastic, having the ability to drastically change their above and below ground architecture in response to changing conditions. These changes in conditions, which may only be local to a specific plant part, can be communicated throughout the plant via long distance signals, including plant hormones, to elicit a plant-wide coordinated response. My research is concerned with the regulation of the above ground shoot architecture, or branching, and how different signals interact to control when, where and how a tiny bud will grow into a branch. This is an important plant trait, being a major determinant of yield in field, horticulture and forestry crops.

The interplay of multiple factors (including hormonal, developmental and environmental) coordinately act to regulate bud outgrowth. The plant hormones strigolactone and auxin inhibit bud outgrowth, while cytokinin promotes outgrowth. Environmental and developmental factors (i.e. photoperiod/daylength, position of axillary bud along stem) and many flowering genes also influence bud outgrowth, particularly the patterns of outgrowth. For example, photoperiod substantially affects the position of branches along the stem, even in decapitated and strigolactone-deficient plants, and therefore does not require the branching hormone strigolactone. Photoperiod regulation of branching patterns is not solely attributable to the process of flowering, as some mutants that do not flower under any photoperiod still display photoperiod-responsive vegetative traits.

My research, using the model plant garden pea (Pisum sativum), seeks to discover how strigolactones and other known hormones/signals regulate shoot architecture in response to environmental factors (photoperiod) and in coordination with developmental processes (flowering). I am studying the interactions between pathways controlling photoperiod, light response, flowering and branching which will help me to identify factors that determine position of branches along the stem. Understanding such crosstalk is important and will be an important step towards targeted modification of plant architecture, enabling bud outgrowth to be directed to desired regions or stages of plant growth.

Originally from Ireland, Rebecca Dunlop completed her BSc (Honours) degree in Environmental Biology followed by her PhD in fish neuroethology, both from The Queen’s University of Belfast. She migrated Australia in 2004 to undertake a post-doc in humpback whale social communication at UQ where the research resulted in a number of highly cited papers, solidifying her international reputation as a leader and expert in large whale communication and social behaviour. She then began lecturing in the School of Veterinary Science in 2010, mainly in animal physiology and moved to the School of Biological Sciences in 2021 to take up a lecturing position in animal behaviour and physiology.

Research

Rebecca'a research interests are in animal physiology, behaviour, and communication. She mainly works on humpback whales, though has worked on bottlenose dolphins, beaked whales, pilot whales, and false killer whales. Her lab focuses on four main research areas: cetacean acoustic communication, hearing, and behaviour; the effects of noise on humpback communication, behaviour, and physiology; humpback whale social behaviour; and endocrine physiology in cetaceans. Her past and current PhD students and honours students all work within these core research areas.

She is, or has been, a P.I in several large collaborative projects aimed at determining the effects of noise on large whale behaviour and hearing in large whales. Understanding underwater noise impacts on marine mammals is a scientific area that is growing due to interest from the Navy, Oil and Gas companies, the vessel industry and from other ocean stakeholders such as whale watching companies.

Her work on social behaviour and reproductive behaviour uses a combination of behavioural and physiological indicators of reproductive status as well as stress and she currently has an endocrinology lab based at Moreton Bay Research Station. She also collaborates with researchers within the school of veterinary science to develop projects on large whale health and disease.

Genetics of mental health (new research)

We are using the genetic model organism, C. elegans, do investigate the genetic basis of both normal and disordered behaviour. Our current interests are identifying the genes responsible for anxiety and depression as well as the genes for eating disoders and addiction. Using C. elegans as a model organism will also allow us to study gene function as it relates to behaviour.

Molecular mechanisms of phosphine resistance (other research)

Genetic mapping of oxidative stress resistance genes. The fumigant phosphine disrupts oxidative metabolism, resulting in the production of reactive oxygen intermediates. This causes the premature ageing and death of targeted pests. Insect pests of stored grain in Australia now exhibit resistance to phosphine at levels more than 200 times the normal lethal dose.

We have genetically mappedf and identified the genes responsible for phosphine resistance in tall major insect pests of stored grain. We are using a systems biology approach in the model organism C. elegans to understand the molecular basis of phosphine action. Our genetic studies have recently shown that resistance to phosphine is associated with an extension of lifespan

Birgitta Ebert’s research focuses on developing biotechnology concepts to address critical challenges such as pollution, climate change and overexploitation of natural resources.

She specializes in improving microbial catalysts for eco-friendly chemical and material production by leveraging metabolic engineering, synthetic biology, systems analysis, and modelling. Her goal is to create microbial cell factories that convert renewable resources and waste into valuable products, reducing reliance on petrochemicals. She collaborates closely with chemists and chemical engineers to enhance the integration of chemical and biological processes for improved efficiency and sustainability.

Birgitta has a background in Chemical Engineering and a PhD in Systems Biotechnology from TU Dortmund University (Germany). She led a research group in Systems Metabolic Engineering at the Institute of Applied Microbiology at RWTH Aachen University (Germany) from 2012 to 2019. In 2016, she expanded her expertise in Synthetic Biology by joining the Keasling lab at the University of California in Berkeley and the Joint BioEnergy Institute in Emeryville (USA).

Since April 2019, she has been at the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland, applying her expertise to engineer microbial cell factories for fermentation-based manufacturing.

Dr Daniel Edge-Garza is a horticulture and crop geneticist at the Queensland Alliance for Agriculture and Food Innovation at the University of Queensland, Australia. His research interests are to develop and translate tools using genome-wide DNA information for breeders and growers to make meaningful decisions. Daniel’s PhD awarded by the University of Queensland in 2024 focused on identifying global G x E patterns to assist with improved germplasm-environment matching for commercial deployment. Before joining QAAFI, he obtained his Bachelor's Degree in Biological Sciences in 2005 and Master's Degree in Biotechnology in 2009 both at California State University, Fresno. From 2008, he worked as a faculty associate in research for tree fruit breeding at Washington State University becoming recognized worldwide for his efforts to streamline the deployment of DNA tests for pome and stone fruit breeding programs. He has also collaborated with the Genome Database for Rosaceae since 2018 to curate genomics data and train breeders on how to upload and access their data on the Breeding Information Management System.

Dr Bill Ellis is an ecological researcher based in the School of The Environment. He gained a BSc with honours in Zoology at The Australian National University and holds a Master of Environmental Law from the same institution. Bill graduated with a PhD in Zoology from The University of Queensland in 1998 and completed a postdoctoral fellowship at San Diego Zoo's Centre for Research on Endangered Species in 2011.

I am an entomologist with a research interest focused on studying host-pathogen interactions and discovering insect-specific viruses. I have investigated gene expression and the role of small non-coding RNAs in various host-pathogen models, particularly in crucial agricultural pests and medically significant vectors like the Aedes aegypti, responsible for transmitting dengue and Zika viruses. My previous project, aimed at exploring the function of Oryctes rhinoceros nudivirus in the biological control of the coconut rhinoceros beetle in the Pacific Islands, has substantially enhanced our comprehension of this invasive pest within the framework of an offshore biosecurity strategy. By establishing industry partnerships and securing funding to improve the Australian sugar industry, one of Australia's largest agricultural sectors, I have been able to focus on entomopathogenic viruses that affect root-feeding pests in sugarcane.

David Evans is an NHMRC Leadership Fellow and Professor of Statistical Genetics at the University of Queensland Institute for Molecular Bioscience. He is a winner of the NHMRC Marshall and Warren Award.

He completed his PhD in Statistical Genetics at the University of Queensland in 2003, before undertaking a four-year post-doctoral fellowship at the Wellcome Trust Centre for Human Genetics, University of Oxford where he worked as part of the The International HapMap Consortium and co-led the analysis of four diseases within the first Wellcome Trust Case Control Consortium. In 2007 he moved to take up a Senior Lecturer position at the University of Bristol where he led much of the genome-wide association studies work in the Avon Longitudinal Study of Parents and Children (ALSPAC). In 2013 he returned to take up a chair at the University of Queensland whilst continuing to lead an MRC Programme in statistical genetics at the University of Bristol.

His research interests include the genetic mapping of complex traits and diseases (including birthweight and other perinatal traits, osteoporosis, ankylosing spondylitis, sepsis, laterality) and the development of statistical methodologies in genetic epidemiology including approaches for gene mapping, individual risk prediction, causal modelling and dissecting the genetic architecture of complex traits. He has a particular interest in Mendelian randomization and has used it and other causal methods to investigate the Developmental Origins of Health and Disease (DOHaD)- the idea that adverse intrauterine exposures lead to increased risk of disease in later life.

He is Academic Codirector at the NIH funded International Workshop on Statistical Genetics Methods and is faculty on the European Programme in Educational Epidemiology.

He is Associate Editor at the International Journal of Epidemiology and Behavior Genetics journals.

Prof Darryl Eyles is the head of the Queensland Centre for Mental Health Research Developmental Neurobiology laboratory. One of Darryl’s research directions is focused on how known risk-factors for schizophrenia change the way the brain develops. His group have established the biological plausibility of various epidemiological risk factors for this disease including developmental vitamin D deficiency, prenatal hypoxia and maternal immune activation. Strikingly all these exposures affect the early development and later differentiation of early dopamine neurons. A second major focus is on understanding the effects of increased dopamine release in selective circuits and how this may be causal in schizophrenia. A third major interest is in factors such as the gut microbiome, and how increased testosterone contribute to altered brain function related to autism.

The first half of my academic career was focused on neuroscience research. My PhD looked at the modification of processing of painful information in the spinal cord by analgesics. Following my PhD, I investigated the electrical activity and properties of neurons in the amygdala, a brain region attributed with processing and mediating emotions and emotional memories. In addition I became interested in the prefrontal cortex, a brain region that is important for emotion regulation. I studied mechanisms involved in synaptic transmission and synaptic plasticity in the amygdala and prefrontal cortex, with a focus on the role of potassium channels, including SK channels.

For the second half of my career I have moved into a more teaching-focused role. This was first as a casual academic in the School of Biomedical Sciences, from 2014-2020, and since 2021 as a teaching-focused lecturer, with my current research in the Scholarship of Teaching and Learning. My research interests are primarily now in looking at emotions, emotion regulation and motivation regulation during learning, and how these can be harnessed to improve student experiences and learning outcomes. I'm also extremely interested in the development of transferable skills in undergraduates, such as science communication, critical thinking, and cultural capability, in preparation for their future lives and careers.

Honours projects are currently available with myself and others in the SBMS Biomedical Education Research Group, looking at:

• The use of motivation strategies to improve undergraduate student experiences and learning outcomes.
• Effective emotion regulation strategies in first year undergraduate students.

Professor Fairlie is an NHMRC Research Investigator Fellow (Level 3) (2022-present), a Node Leader of the ARC Centre of Excellence for Innovations in Peptide Protein Science, one of four Centre Directors and former Head of the Division of Chemistry of Structural Biology at the Institute for Molecular Bioscience (since 2009), and an Affiliate Professor of the School of Chemistry and Molecular Biosciences. He was previously an NHMRC Senior Principal Research Fellow (2012-2021), a Node Leader at the ARC Centre of Excellence in Advanced Molecular Imaging (2014-2021), an ARC Federation Fellow (2006-2011), an ARC Professorial Fellow (2002-2006), and Scientific Director and Chief Scientific Officer of a startup company. He undertook postdoctoral studies at Stanford University and University of Toronto, postgraduate studies at Australian National University and University of New South Wales, and undergraduate studies at University of Adelaide.

His research group works across the disciplines of chemistry (synthesis, structure, reaction mechanisms), biochemistry (enzyme inhibitors, protein-protein interactions, GPCRs, transcription factors), immunology (innate immune cells in health and disease, mucosal T cells), and pharmacology (molecular pharmacology and human cell signalling, experimental pharmacology in rodent models of human diseases). He has published over 480 scientific journal articles in high impact chemistry journals (e.g. Chem Rev, Acc Chem Res, J Am Chem Soc, Angew Chem Int Edit, Chem Sci, J Med Chem, Org Lett, J Org Chem) and biology journals (e.g. Nature, Science, Nat Rev Endocrinol, Mol Cancer, Immunity, Nature Immunology, Science Immunology, Am J Resp Crit Care Med, J Hepatol, Trends Immunol, Mol Neurodegen, Adv Drug Deliv Rev, Nature Communications, Trends Pharmacol Sci, J Exp Med, J Clin Invest, Kidney Int, Arthritis & Rheum, Science Advances, Pharmacol Ther, Cancer Res, Proc Natl Acad Sci USA, Dev Cell, Curr Biol, J Cell Biol, Cell Reports, PloS Biol, Br J Pharmacol, JCI Insight, Diabetes, Mucosal Immunol, etc). He has been a Highly Cited Researcher (Clarivate Analytics), with over 37,000 citations and 113 publications with over 100 citations (Google Scholar), and has collaborated with many of the world’s largest pharmaceutical and biotechnology companies.